Caption Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,000
Closed -$77.3K 2050
2025
Q3
$77.3K Buy
+10,000
New +$78K ﹤0.01% 1548
2022
Q2
Sell
-100,000
Closed -$7.21M 1823
2022
Q1
$7.21M Buy
100,000
+50,000
+100% +$3.6M 0.09% 313
2021
Q4
$4.59M Buy
50,000
+3,600
+8% +$430K 0.05% 483
2021
Q3
$5.88M Hold
46,400
0.07% 381
2021
Q2
$7.71M Buy
46,400
+29,400
+173% +$4.76M 0.1% 260
2021
Q1
$3.09M Sell
17,000
-43,000
-72% -$9.97M 0.07% 380
2020
Q4
$12M Hold
60,000
0.27% 94
2020
Q3
$13.2M Hold
60,000
0.31% 70
2020
Q2
$11.4M Hold
60,000
0.38% 45
2020
Q1
$9.3M Sell
60,000
-40,000
-40% -$4.65M 0.53% 33
2019
Q4
$8.37M Buy
100,000
+40,000
+67% +$3.04M 0.28% 81
2019
Q3
$4.06M Hold
60,000
0.21% 127
2019
Q2
$3.98M Buy
+60,000
New +$3.5M 0.2% 153
2018
Q1
Sell
-200,000
Closed -$6.97M 321
2017
Q4
$6.97M Buy
+200,000
New +$6.64M 0.72% 47

Other funds holding TDOC

Caption Management's TDOC Position: Q1 2026 in Review

Caption Management reduced its Teladoc Health (TDOC) stake by 68% in Q1 2026, selling an estimated $29K and leaving 2,439 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1464.

Caption Management first reported a position in TDOC in Q2 2019 and has held it in 15 quarters since. The position peaked at $2.9M in Q3 2021. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Caption Management held 2,439 shares of Teladoc Health worth $13.3K as of Q1 2026.
  • Caption Management sold 5,160 Teladoc Health shares in Q1 2026, an estimated $29K.
  • Teladoc Health made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1464 holding.
  • Caption Management first reported a position in Teladoc Health in Q2 2019 and has held it in 15 quarters since.
  • Caption Management's Teladoc Health position peaked at $2.9M in Q3 2021.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.